Author details

Full Name

Geoffrey Neale

Affiliation

St. Jude Children's Research Hospital

ORCID

Career Start Year

1989

Papers

177

H Index

Expertise

CM4AI Collaborator

Antoine Forget (CM4AI)

PMID	Paper Title	Journal Title	Published Year
36256508	Social-epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors.	Cancer Commun (Lond)	2023
37115548	Epigenetic Age in Peripheral Blood Among Children, Adolescent, and Adult Survivors of Childhood Cancer.	JAMA Netw Open	2023
36855205	Distinct DNA methylation signatures associated with blood lipids as exposures or outcomes among survivors of childhood cancer: a report from the St. Jude lifetime cohort.	Clin Epigenetics	2023
36851695	How Estrogen, Testosterone, and Sex Differences Influence Serum Immunoglobulin Isotype Patterns in Mice and Humans.	Viruses	2023
35109748	Blood DNA methylation signatures are associated with social determinants of health among survivors of childhood cancer.	Epigenetics	2022
35452499	Astrovirus-induced epithelial-mesenchymal transition via activated TGF-Î² increases viral replication.	PLoS Pathog	2022
36302969	PTENï»¿ directs developmental and metabolic signaling for innate-like T cell fate and tissue homeostasis.	Nat Cell Biol	2022
36127469	Haploinsufficiency of the lysosomal sialidase NEU1 results in a model of pleomorphic rhabdomyosarcoma in mice.	Commun Biol	2022
35982322	Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.	Acta Neuropathol	2022
35313970	Genome-wide association studies identify novel genetic loci for epigenetic age acceleration among survivors of childhood cancer.	Genome Med	2022
32970815	Epigenetic Age Acceleration and Chronic Health Conditions Among Adult Survivors of Childhood Cancer.	J Natl Cancer Inst	2021
33823916	Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime Cohort.	Genome Med	2021
33619117	A MyD88/IL1R Axis Regulates PD-1 Expression on Tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma.	Cancer Res	2021
33637564	The Common Germline <i>TP53-R337H</i> Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model.	Cancer Res	2021
34678152	Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.	Cancer Cell	2021
34413129	SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging Agents.	Mol Cancer Ther	2021
33405951	Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).	J Clin Oncol	2021
33374007	Cohort Profile: The St. Jude Lifetime Cohort Study (SJLIFE) for paediatric cancer survivors.	Int J Epidemiol	2021
32289155	Hippo/Mst signaling coordinates cellular quiescence with terminal maturation in iNKT cell development and fate decisions.	J Exp Med	2020
32086311	Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs.	Cancer Discov	2020
31722972	Mevalonate metabolism-dependent protein geranylgeranylation regulates thymocyte egress.	J Exp Med	2020
32105583	From Influenza Virus Infections to Lupus: Synchronous Estrogen Receptor <i>Î±</i> and RNA Polymerase II Binding Within the Immunoglobulin Heavy Chain Locus.	Viral Immunol	2020
31911938	Homeostasis and transitional activation of regulatory T cells require c-Myc.	Sci Adv	2020
33140051	Synergism of TNF-Î± and IFN-Î³ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.	bioRxiv	2020
32637605	XAF1 as a modifier of p53 function and cancer susceptibility.	Sci Adv	2020
32793890	Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.	Blood Cancer Discov	2020
32651255	Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer.	Cancer Res	2020
32698014	Tissue-Specific Regulation of the Wnt/Î²-Catenin Pathway by PAGE4 Inhibition of Tankyrase.	Cell Rep	2020
32150572	Interferon inducible GBPs restrict Burkholderia thailandensisÂ motility induced cell-cell fusion.	PLoS Pathog	2020
32238299	Expansion and CD2/CD3/CD28 stimulation enhance Th2 cytokine secretion of human invariant NKT cells with retained anti-tumor cytotoxicity.	Cytotherapy	2020
32296180	Germline Elongator mutations in Sonic Hedgehog medulloblastoma.	Nature	2020
30407507	Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers.	Int Immunol	2019
31862972	Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor.	Nat Commun	2019
31350825	Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML.	Clin Transl Sci	2019
31399583	MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat.	Nat Commun	2019
30911060	LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity.	Cell Res	2019
30818795	Will Attention by Vaccine Developers to the Host's Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success?	Vaccines (Basel)	2019
30568299	Metabolic heterogeneity underlies reciprocal fates of T<sub>H</sub>17 cell stemness and plasticity.	Nature	2019
29321274	IRF1 Is a Transcriptional Regulator of ZBP1 Promoting NLRP3 Inflammasome Activation and Cell Death during Influenza Virus Infection.	J Immunol	2018
30231985	SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer.	Immunity	2018
29980617	Metabolic signaling directs the reciprocal lineage decisions of Î±Î² and Î³Î´ T cells.	Sci Immunol	2018
29849151	Hippo/Mst signalling couples metabolic state and immune function of CD8Î±<sup>+</sup> dendritic cells.	Nature	2018
29844370	mTOR coordinates transcriptional programs and mitochondrial metabolism of activated T<sub>reg</sub> subsets to protect tissue homeostasis.	Nat Commun	2018
30523785	The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number.	Dev Cell	2018
30413360	Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.	Immunity	2018
29576451	IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation.	Cell	2018
29399633	Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.	Sci Adv	2018
27994150	Gfi1-Foxo1 axis controls the fidelity of effector gene expression and developmental maturation of thymocytes.	Proc Natl Acad Sci U S A	2017
29133930	PLCÎ³-dependent mTOR signalling controls IL-7-mediated early B cell development.	Nat Commun	2017
29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	J Natl Cancer Inst	2017

1 - 50 of 177

Camille Lobry

INSERM U1170, Universite Paris Saclay

Career Start Year 2007

Number of shared co-authors 2

Christopher Y Park

NYU Robert I. Grossman School of Medicine

Career Start Year 2006

Number of shared co-authors 3

Maggie Cam

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2005

Number of shared co-authors 0

Michael Gombert

Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf

Career Start Year 2004

Number of shared co-authors 14

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 1

Donghui Cheng

University of California los angeles

Career Start Year 2003

Number of shared co-authors 0

Hans-J??rg Warnatz

Max Planck Institute for Molecular Genetics

Career Start Year 2002

Number of shared co-authors 33

Jacqueline E Payton

Washington University School of Medicine.

Career Start Year 2001

Number of shared co-authors 9

Wendy Dubois

Center for Cancer Research, National Cancer Institute

Career Start Year 2000

Number of shared co-authors 0

Andrew J Gentles

Stanford Center for Biomedical Informatics Research, Stanford University

Career Start Year 1999

Number of shared co-authors 0

David M Weinstock

Merck & Co.

Career Start Year 1998

Number of shared co-authors 9

Kevin S Smith

Stanford University

Career Start Year 1997

Number of shared co-authors 1

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 2

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 1

Jean Soulier

University of Paris

Career Start Year 1993

Number of shared co-authors 9

Seishi Ogawa

Kyoto University

Career Start Year 1993

Number of shared co-authors 5

Ute Fischer

Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf

Career Start Year 1992

Number of shared co-authors 16

Arndt Borkhardt

Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf

Career Start Year 1992

Number of shared co-authors 35

Glenn M Marshall

Children's Cancer Institute, Lowy Cancer Research Centre

Career Start Year 1989

Number of shared co-authors 15

Tarik M??r??y

Institut de recherches cliniques de Montreal

Career Start Year 1985

Number of shared co-authors 1

Karen Cerosaletti

Center for Translational Immunology

Career Start Year 1985

Number of shared co-authors 1

Toshio Kitamura

The University of Tokyo.

Career Start Year 1984

Number of shared co-authors 1

Louis M Staudt

National Cancer Institute, National Institutes of Health

Career Start Year 1983

Number of shared co-authors 9

Timothy J Ley

Washington University School of Medicine

Career Start Year 1982

Number of shared co-authors 26

Alex Look

Dana-Farber Cancer Institute

Career Start Year 1975

Number of shared co-authors 27

Daniel G Tenen

Harvard Stem Cell Institute, Harvard Medical School

Career Start Year 1975

Number of shared co-authors 2

Bruce J Aronow

Cincinnati Children's Hospital Medical Center

Career Start Year 1975

Number of shared co-authors 6

Louise C Showe

The Wistar Institute

Career Start Year 1975

Number of shared co-authors 0

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 42

Tak W Mak

Princess Margaret Cancer Centre, University Health Network

Career Start Year 1970

Number of shared co-authors 7

row(s) 1 - 30 of 30